Suchergebnisse - "Dodd, Lori E"

PubPharm (117)

1

SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir

enthalten in: The Journal of infectious diseases | 2024

von Singh, K. | Rubenstein, K. | Callier, V. | +125

2

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19 : A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

enthalten in: Annals of internal medicine | 2024

von Paules, C. | Wang, J. | Tomashek, K. | +18

3

Vaccines for Mpox - An Unmet Global Need

enthalten in: NEJM evidence | 2024

von Dodd, L. | Lane, H. | Muyembe-Tamfum, J.

4

Evaluating Demographic Representation in Clinical Trials : Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

enthalten in: Open forum infectious diseases | 2023

von Ortega-Villa, A. | Hynes, N. | Levine, C. | +39

5

Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections

enthalten in: Open forum infectious diseases | 2023

von Sweeney, D. | Tuyishimire, B. | Ahuja, N. | +27

6

On the importance and challenges of global access to proven life-saving treatments for Ebolavirus

enthalten in: The Lancet. Infectious diseases | 2023

von Mbaya, O. | Kingebeni, P. | Dodd, L. | +2

CommentOn: Lancet Infect Dis. 2023 Jan 19;:null. - PMID 36682365

7

Counting Monkeypox Lesions in Patient Photographs : Limits of Agreement of Manual Counts and Artificial Intelligence

enthalten in: The Journal of investigative dermatology | 2023

von McNeil, A. | House, D. | Mbala-Kingebeni, P. | +9

8

Noninferiority testing with censoring when the event rate is low

enthalten in: Statistics in medicine | 2022

von Gallagher, S. | Wang, J. | Lumbard, K. | +2

9

Subgroup Analyses : Subpar or Sublime?

enthalten in: NEJM evidence | 2022

von Hughes, E. | Takvorian, K. | Dodd, L. | +5

10

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4) : a randomised, double-blind, double placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Wolfe, C. | Tomashek, K. | Patterson, T. | +162

CommentIn: Ann Intern Med. 2022 Oct;175(10):JC115. - PMID 36191322

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]